Heron Therapeutics hits record low on bigger-than-expected Q1 loss

Heron Therapeutics

12/05/2023 18:17

** Shares of drugmaker Heron Therapeutics Inc  HRTX.O  drop
36.1% to $1.425, an all-time low
    ** Co posts Q1 net loss of 27 per share, below analysts' est
for loss of 20 cents per share - Refinitiv
    ** Q1 net product sales was in line with analysts' est at
$29.6 mln
    ** As of March 31, HRTX had cash, cash equivalents and
short-term investments of $60 mln vs $84.9 mln as of Dec 31
    ** Shares down ~42% YTD

 (Reporting by Yamini Kalia in Bengaluru)
 ((Yamini.Kalia@thomsonreuters.com))